Paragonix Technologies has unveiled TempLock™, a groundbreaking temperature stabilization technology integrated into its SherpaPak® Cardiac Transport System, designed to enhance the preservation of donor hearts during transport. This innovation, showcased at ISHLT 2026, ensures consistent temperatures maintained within a controlled range of 4-8°C for extended periods, addressing the increasing ischemic times faced by transplant surgeons in the U.S. As clinical practices evolve towards longer-distance procurements, TempLock offers greater control and flexibility in donor heart preservation.

The significance of this development lies in its potential to improve transplant outcomes. The SherpaPak System has already demonstrated superior results compared to traditional ice storage methods, with recent studies highlighting its capability to enhance survival rates post-transplantation. The integration of TempLock further refines the preservation conditions during the critical window between procurement and transplantation, aligning with the real-world challenges faced by transplant teams. Dr. Lisa Anderson, President of Paragonix Technologies, emphasized that this evolution is rooted in the need for reliability and consistency, ultimately aiming to deliver every possible advantage to transplant teams and their patients.

This advancement shifts the landscape of heart preservation research and clinical practice by setting a new standard for organ transport technologies. The enhanced temperature control provided by TempLock not only optimizes preservation but also supports the growing trend of extended donor heart ischemic times. As the field moves towards more complex transplant scenarios, the SherpaPak System’s capabilities could significantly influence drug development timelines and clinical protocols, ultimately improving patient outcomes in heart transplantation.

Source: globenewswire.com